Fiscal Year 2025 First Quarter Results August 6, 2024 Today's Speakers Erik Hirsch Co-CEO Griff Norville Head of Technology Solutions Jeff Armbrister Chief Financial Officer John Oh Head of Shareholder Relations Hamilton Lane | Global Leader in the Private Markets 2 Period Highlights Business Performance • Assets under management and fee-earning assets under management were $130 billion and $68 billion, respectively, as of June 30, 2024, increases of 11% and 13%, respectively, compared to June 30, 2023 • Ma ...

Capital Southwest Corporation | --- | --- | |------------------------------------------------------------------------------------------------|-------| | | | | Q1 2025 Earnings Presentation August 6, 2024 | | | 8333 Douglas Avenue, Suite 1100 \| Dallas, Texas 75225 \| 214.238.5700 \| capitalsouthwest.com | | Important Notices • These materials and any presentation of which they form a part are neither an offer to sell, nor a solicitation of an offer to purchase, any securities of Capital Southwest. • These m ...

HAGERTY. Q2 // 2024 Investor Presentation SPEAKERS: McKeel Hagerty | Chief Executive Officer and Chairman Patrick McClymont | Chief Financial Officer FORWARD LOOKING STATEMENTS / NON-GAAP FINANCIAL MEASURES This presentation contains statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. These forward-looking statements reflect our current expectations ...

Rhythm Pharmaceuticals Second Quarter 2024 Financial Results and Business Update August 6, 2024 ® © Rhythm® Pharmaceuticals, Inc. All rights reserved. On Today's Call David Connolly, Executive Director of Investor Relations and Corporate Communications David Meeker, MD, Chair, President and Chief Executive Officer Jennifer Lee, Executive Vice President, Head of North America Yann Mazabraud, Executive Vice President, Head of International Hunter Smith, Chief Financial Officer ® 2 Forward-looking Statements T ...

Investor Presentation August 2024 NYSE: AESI Important Disclosures Forward-Looking Statements This Presentation contains "forward-looking statements" of Atlas Energy Solutions Inc. ("Atlas," the "Company," "AESI," "we," "us" or "our") within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are predictive or prospective in nature, that depend upon or refer to future events or conditions or that include th ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | Note: References to The Kinetic Group and Revelyst in the presentation refer to the former Sporting Products and Outdoor Products segments of Vista Outdoor, respectively. Additionally, in the results that follow when referring to "Revelyst", it comprises three new operating and reportable segments: Revelyst Adventure Sports, Revelyst Precision Sports Technology and Revelyst Outdoor Performance. Please see Vista Outdoor's Annual Report on Form 10- ...

Where Intelligence Meets Infrastructure® Earnings Conference Call 2024 Third Quarter June 30, 2024 August 6, 2024 These slides are not intended to be a stand-alone presentation, but are for use in conjunction with the earnings call Non-GAAP Measures In an effort to provide investors with additional information regarding the Company's results as determined by accounting principles generally accepted in the United States ("GAAP"), the Company also provides non-GAAP information that management believes is usef ...

Quaker Houghton Second Quarter 2024 Results Investor Conference Call Quaker Houghton.. Forward Together Forward-Looking Statements Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles ("GAAP"). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and helps investors to evaluate the financial results of the Company. These measur ...

米 908 devices Analysis at the speed of life AUGUST 2024 Forward looking statements / Non-GAAP financial measures This presentation and the accompanying oral presentation (this "presentation") contain forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may relate to, but are not limited to, expectations of future results of operations or financial performance of 9 ...

Tara Living with narcolepsy Taking WAKIX since 2020 Q2 2024 Financial Results August 6, 2024 Forward-Looking Statements 2 This presentation includes forward‐looking statements within the meaning of the Private Securities Reform Act of 1995. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding Harmony Biosciences Holdings, Inc.'s (the "Company") future financial position, business strategy and plans and objectives of management for ...